BioClinica, C.R. Bard win Microsoft award

Companies awarded 2012 Microsoft Corporation’s Life Sciences Innovation Award for “Monitor Visit Report” capability present in its OnPoint Clinical Trial Management System

Kelsey Kaustinen
NEWTON, Pa.—BioClinica, Inc. announced that in conjunctionwith C.R. Bard, it has been named a 2012 winner of Microsoft Corporation's LifeSciences Innovation Award. The awards are presented to companies that utilizeMicrosoft solutions to actualize business and information technology benefits,and were announced at the Drug Information Association's 48th Annual Meeting inPhiladelphia. BioClinica was recognized with the reward for revolutionizingmedicine development by helping its clients to get therapeutic breakthroughs tomarket faster, combat serious illnesses, improve healthcare and improvepatients' quality of life.
 
 
"Now more than ever, the life sciences industry isfaced with many challenges including cutting costs and bringing new drugs andtherapies to market faster," Andrea McGonigle, national managing directorof Life Sciences at Microsoft Corporation, said in a press release. "Weare impressed with how the winners demonstrate sustainable impacts throughtechnology, and are proud that Microsoft's software plays an important role inenabling these achievements in life sciences."
 
 
BioClinica's focus is the provision of comprehensiveclinical trial design and management for pharmaceutical, biotechnology andmedical device companies, the organization notes on its website. The companyoffers clinical trial management services with the aid of imaging core lab,electronic data capture, "clinical supply chain forecasting and optimizationsolutions." BioClinica offers services throughout all phases of clinicaltrials.
 
 
C.R. Bard develops, manufactures and markets medicaltechnologies in the fields of vascular, urology, oncology and surgicalspecialty, and markets to hospitals, extended care facilities and individualhealth care professionals.
 
 
With the award, BioClinica was recognized for the "MonitorVisit Report" capability present in its OnPoint Clinical Trial ManagementSystem (CTMS), which was developed for C.R. Bard. The program makes its easier forclinical site monitors to input necessary and relevant study information, andby syncing local Microsoft Word documents through SharePoint, the data thenbecomes a connected list, which in turn is transferred and updated withinOnPoint CTMS. This offers site monitors the ability to complete forms anywhereand to synchronize their data with the web-based CTMS system as long asInternet access is available, offering both time savings and trial costreductions.
 
 
"We are honored to have C.R. Bard and BioClinicareceive this award in recognition of our partnership to bring new innovationsto market," Peter Benton, president of the eClinical Division of BioClinica,said in a press release. "The power of being able to run a clinical trial fromone's Microsoft Outlook client is extremely powerful as visit reports, open actionitems, clinical documents and monitoring visits are available everywhere,anytime. The moment you connect toa network everything is instantly updated, something which no other CTMS orclinical suite of products has the power to do."
 
BioClinica and C.R. Bard were selected for the award fromamong a number of other life-sciences corporations in the pharmaceutical,biotechnology and medical device industries, all of which are working on thecreative application of technology for the development of therapeuticinnovations. The winners were selected by a panel of industry experts.
 
 
 
 
SOURCE: BioClinica, Inc. press release

Kelsey Kaustinen

Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Front Cover

Latest Issue  

• Volume 18 • Issue 12 • December 2022/January 2023

December 2022/January 2023

December 2022/January 2023 issue